OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
02 February 2018 - 10:00PM
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care
diagnostic tests and specimen collection devices, today announced
the appointment of Dr. Aradhana Sarin, as a member of the Company's
Board of Directors. Dr. Sarin will serve as a Class II Director
with an initial term expiring at the Company’s 2020 Annual Meeting
of Stockholders. She will also serve on the Audit Committee and
Nominating and Corporate Governance Committee of the Board.
“As OraSure continues to grow and execute
against its strategic priorities, we welcome the addition of
Aradhana to our Board of Directors,” said Stephen S. Tang, Ph.D.,
Chairman of the Board. “Aradhana’s many years of experience in the
healthcare industry, first as a medical doctor and then as an
investment banker, will add a valuable new perspective and skill
set to our Board. With her long and successful track record
in leading the healthcare practice of a major investment bank,
Aradhana brings not only executive leadership to the Board but also
extensive knowledge in business development and strategic matters,
both of which will be critical as the Company pursues its future
growth strategy.”
Dr. Sarin, 43, currently serves as Senior Vice
President, Head of Corporate Business Development & Strategy
for Alexion Pharmaceuticals, a global biopharmaceutical company
that is serving patients and families affected by rare diseases
through the innovation, development and commercialization of
life-changing therapies. Dr. Sarin also serves as Co-Chair of the
Executive Management Committee overseeing Science and Innovation at
Alexion.
Dr. Sarin brings over 20 years of professional
experience at global financial institutions. She has extensive
knowledge of global healthcare systems, and has closed over 100
M&A, equity and debt financing transactions. Prior to Alexion,
Dr. Sarin was at Citi Global Banking, where she served as the
Managing Director of Healthcare Corporate & Investment Banking,
focusing on clients in the diagnostics, life sciences and
biopharmaceutical sectors. Prior to joining Citi, Dr. Sarin served
as Managing Director of Healthcare Investment Banking at UBS, where
she led a number of complex M&A deals. Prior to this, Dr. Sarin
worked at JP Morgan in the M&A Advisory and Healthcare groups
focusing on transaction execution. Before her banking career, Dr.
Sarin spent two years as a medical resident doctor practicing in
both India and Africa. Dr. Sarin has a strong orientation for
science, an excellent understanding of the entire healthcare
sector, extensive relationships, and deep transactional experience.
Dr. Sarin received her MBA from Stanford Business School and
obtained her medical training from the University of Delhi.
About OraSure Technologies
OraSure Technologies is a leader in the
development, manufacture and distribution of point of care
diagnostic and collection devices and other technologies designed
to detect or diagnose critical medical conditions. Its
first-to-market, innovative products include rapid tests for the
detection of antibodies to HIV and HCV on the OraQuick® platform,
oral fluid sample collection, stabilization and preparation
products for molecular diagnostic applications, and oral fluid
laboratory tests for detecting various drugs of abuse. OraSure's
portfolio of products is sold globally to various clinical
laboratories, hospitals, clinics, community-based organizations and
other public health organizations, research and academic
institutions, distributors, government agencies, physicians'
offices, commercial and industrial entities and consumers. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health. For more information on
OraSure Technologies, please visit www.orasure.com.
Company contact:
Ronald H. Spair
Chief Financial Officer
610-882-1820
investorinfo@orasure.com
Shauna White
Corporate Marketing Manager
484-353-1575
media@orasure.com
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024